A Glimpse of Ascendis Pharma's Earnings Potential

Ascendis Pharma ASND is preparing to release its quarterly earnings on Thursday, 2024-11-14. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Ascendis Pharma to report an earnings per share (EPS) of $-1.66.

Ascendis Pharma bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Earnings Track Record

During the last quarter, the company reported an EPS missed by $0.50, leading to a 11.27% drop in the share price on the subsequent day.

Here's a look at Ascendis Pharma's past performance and the resulting price change:

Performance of Ascendis Pharma Shares

Shares of Ascendis Pharma were trading at $127.67 as of November 12. Over the last 52-week period, shares are up 36.55%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Ascendis Pharma visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.